Background: No prospective analyses of clinical characteristics and prognostic factors on amyotrophic lateral sclerosis(ALS) have been performed in Korea.Methods: The prognosis of 227 sporadic ALS patient with El-Escorial-compatible criteria were evaluated using the serial Korean Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (K-ALSFRS-R), and the progression rate of K-ALSFRS-R (ΔFS=48-ALSFRS-R at the time of diagnosis). Their clinical characteristics and survival times were also analyzed. The endpoint was defined as either time to death or the tracheostomy state. The effects of individual prognostic factors on disease progression were assessed with the Kaplan-Meier life-table method and multivariate Cox proportional re...
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction ...
Amyotrophic lateral sclerosis (ALS) has a fatal outcome in about three years, but survival is known ...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
Background: No prospective analyses of clinical characteristics and prognostic factors on amyotrophi...
Abstract. Background:. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder ass...
������ (Abstract)Background and Purpose Recently published, evidence-based guidelines should alter t...
Background: Accurate information on natural history and prognosis of Amyotrophic Lateral Sclerosis (...
Objectives To describe the natural history and clinical features of sporadic amyotrophic lateral scl...
Objective: To report the latest long-term outcome of amyotrophic lateral sclerosis (ALS) and to anal...
OBJECTIVE: To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS...
OBJECTIVE: To investigate the incidence, prevalence, and demographic factors of all amyotrophic late...
ObjectiveSeveral independent prognostic factors, such as age of onset, type of onset, body mass inde...
Objective Approximately 50% of amyotrophic lateral sclerosis (ALS) patients have cognitive and behav...
Cognitive impairment is associated with a negative prognosis in amyotrophic lateral sclerosis (ALS),...
Objective To capture the clinical patterns, timing of key milestones and survival of patients presen...
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction ...
Amyotrophic lateral sclerosis (ALS) has a fatal outcome in about three years, but survival is known ...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
Background: No prospective analyses of clinical characteristics and prognostic factors on amyotrophi...
Abstract. Background:. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder ass...
������ (Abstract)Background and Purpose Recently published, evidence-based guidelines should alter t...
Background: Accurate information on natural history and prognosis of Amyotrophic Lateral Sclerosis (...
Objectives To describe the natural history and clinical features of sporadic amyotrophic lateral scl...
Objective: To report the latest long-term outcome of amyotrophic lateral sclerosis (ALS) and to anal...
OBJECTIVE: To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS...
OBJECTIVE: To investigate the incidence, prevalence, and demographic factors of all amyotrophic late...
ObjectiveSeveral independent prognostic factors, such as age of onset, type of onset, body mass inde...
Objective Approximately 50% of amyotrophic lateral sclerosis (ALS) patients have cognitive and behav...
Cognitive impairment is associated with a negative prognosis in amyotrophic lateral sclerosis (ALS),...
Objective To capture the clinical patterns, timing of key milestones and survival of patients presen...
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction ...
Amyotrophic lateral sclerosis (ALS) has a fatal outcome in about three years, but survival is known ...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...